Moors & Cabot’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Moors & Cabot's MDT Position: Q2 2026 in Review
Moors & Cabot increased its Medtronic (MDT) stake by 1.6% in Q2 2026, buying an estimated $81.3K and bringing the position to 62,233 shares worth $4.87M. The position accounts for 0.19% of the portfolio, ranked #106.
Moors & Cabot first reported a position in MDT in Q1 2014 and has held it in 50 quarters since. The position peaked at $7.47M in Q1 2022. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Moors & Cabot held 62,233 shares of Medtronic worth $4.87M as of Q2 2026.
- Moors & Cabot bought 1,008 Medtronic shares in Q2 2026, an estimated $81.3K.
- Medtronic made up 0.19% of Moors & Cabot's portfolio in Q2 2026, its #106 holding.
- Moors & Cabot first reported a position in Medtronic in Q1 2014 and has held it in 50 quarters since.
- Moors & Cabot's Medtronic position peaked at $7.47M in Q1 2022.
- 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.